Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "64.00",
    "chg": 0.83,
    "chgp": "1.31%",
    "dir": 1,
    "prev_price": "63.17",
    "mcapval": "181.47 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE198H01019",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "72.28 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3746054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3746054.png",
        "date": "2025-12-04 10:00:16",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit price limit of ₹73.49. The pharmaceutical and biotechnology company’s shares declined by 5.0% intraday, marking the maximum permissible daily loss and reflecting a sharp negative sentiment among investors."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3745889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3745889.png",
        "date": "2025-12-04 09:36:20",
        "description": "Aarey Drugs & Pharmaceuticals has encountered significant selling pressure, with the stock registering a sharp decline of 4.99% today and exhibiting a complete absence of buyers. This marks the third consecutive day of losses, reflecting distress selling signals and a challenging trading environment for the pharmaceutical company."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3743529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3743529.png",
        "date": "2025-12-03 10:00:17",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a sharp decline in investor confidence. The stock closed at ₹77.36, marking a maximum daily loss of 5.01%, significantly underperforming both its sector and the broader market indices."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3743401",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3743401.png",
        "date": "2025-12-03 09:50:51",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the pharmaceutical company’s shares continue to underperform relative to broader market indices and sector benchmarks."
      },
      {
        "title": "Why is Aarey Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarey-drugs-fallingrising-3742555",
        "imagepath": "",
        "date": "2025-12-03 00:59:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s fall on 02-Dec represents a significant underperformance compared to its sector and benchmark indices. While the Sensex recorded a modest gain of 0.65% over the past week, Aarey Drugs declined by 7.37% during the same period. This downward trend extended into the month, with the stock falling 11.17% against the Sensex’s 1.43% rise. The intraday volatility was elevated at 5.24%, signalling considerable price fluctuations throughout the trading session. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting selling pressure dominated the session.</p>\n<p>Despite this short-term weakness, the stock remains well supported by its longer-term fundamentals. It con..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3741866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3741866.png",
        "date": "2025-12-02 14:00:08",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at ₹81.44, marking a 5.0% drop on the day and continuing a downward trend that has seen the stock lose over 10% in the past five sessions."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3741835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3741835.png",
        "date": "2025-12-02 13:30:46",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.88% and exhibiting a complete absence of buyers. This extreme selling activity signals distress within the stock, contrasting sharply with the broader market's relatively muted movement."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-intense-selling-pressure-amid-lower-circuit-lockdown-3737800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3737800.png",
        "date": "2025-12-01 09:45:43",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The pharmaceutical company’s shares have recorded consecutive declines, signalling distress selling and a challenging market environment for the stock."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-downgraded-to-strong-sell-amid-weak-financials-and-mixed-technicals-3737587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_mojoScore_3737587.png",
        "date": "2025-12-01 08:09:07",
        "description": "Aarey Drugs & Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. Despite recent quarterly setbacks and cautious financial metrics, the stock’s long-term returns and evolving technical signals have influenced a nuanced shift in analytical perspective."
      }
    ],
    "total": 540,
    "sid": "933527",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jan-2026",
      "details": "Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Dec-2025",
      "details": "Intimation for Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication of the Unaudited Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-04 10:00:16

Aarey Drugs & Pharmaceuticals Ltd witnessed intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit price limit of ₹73.49. The pharmaceutical and biotechnology company’s shares declined by 5.0% intraday, marking the maximum permissible daily loss and reflecting a sharp negative sentiment among investors.

Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 09:36:20

Aarey Drugs & Pharmaceuticals has encountered significant selling pressure, with the stock registering a sharp decline of 4.99% today and exhibiting a complete absence of buyers. This marks the third consecutive day of losses, reflecting distress selling signals and a challenging trading environment for the pharmaceutical company.

Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-03 10:00:17

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a sharp decline in investor confidence. The stock closed at ₹77.36, marking a maximum daily loss of 5.01%, significantly underperforming both its sector and the broader market indices.

Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn

2025-12-03 09:50:51

Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the pharmaceutical company’s shares continue to underperform relative to broader market indices and sector benchmarks.

Why is Aarey Drugs falling/rising?

2025-12-03 00:59:57

Short-Term Price Movement and Market Context The stock’s fall on 02-Dec represents a significant underperformance compared to its sector and benchmark indices. While the Sensex recorded a modest gain of 0.65% over the past week, Aarey Drugs declined by 7.37% during the same period. This downward trend extended into the month, with the stock falling 11.17% against the Sensex’s 1.43% rise. The intraday volatility was elevated at 5.24%, signalling considerable price fluctuations throughout the trading session. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting selling pressure dominated the session. Despite this short-term weakness, the stock remains well supported by its longer-term fundamentals. It con...

Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-02 14:00:08

Aarey Drugs & Pharmaceuticals Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at ₹81.44, marking a 5.0% drop on the day and continuing a downward trend that has seen the stock lose over 10% in the past five sessions.

Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn

2025-12-02 13:30:46

Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.88% and exhibiting a complete absence of buyers. This extreme selling activity signals distress within the stock, contrasting sharply with the broader market's relatively muted movement.

Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-01 09:45:43

Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The pharmaceutical company’s shares have recorded consecutive declines, signalling distress selling and a challenging market environment for the stock.

Aarey Drugs & Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-01 08:09:07

Aarey Drugs & Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. Despite recent quarterly setbacks and cautious financial metrics, the stock’s long-term returns and evolving technical signals have influenced a nuanced shift in analytical perspective.

View All News